179 related articles for article (PubMed ID: 21778049)
1. CXCR7 is up-regulated in human and murine hepatocellular carcinoma and is specifically expressed by endothelial cells.
Monnier J; Boissan M; L'Helgoualc'h A; Lacombe ML; Turlin B; Zucman-Rossi J; Théret N; Piquet-Pellorce C; Samson M
Eur J Cancer; 2012 Jan; 48(1):138-48. PubMed ID: 21778049
[TBL] [Abstract][Full Text] [Related]
2. CXCR4 expression affects overall survival of HCC patients whereas CXCR7 expression does not.
Neve Polimeno M; Ierano C; D'Alterio C; Simona Losito N; Napolitano M; Portella L; Scognamiglio G; Tatangelo F; Maria Trotta A; Curley S; Costantini S; Liuzzi R; Izzo F; Scala S
Cell Mol Immunol; 2015 Jul; 12(4):474-82. PubMed ID: 25363530
[TBL] [Abstract][Full Text] [Related]
3. CXCR7 functions as a scavenger for CXCL12 and CXCL11.
Naumann U; Cameroni E; Pruenster M; Mahabaleshwar H; Raz E; Zerwes HG; Rot A; Thelen M
PLoS One; 2010 Feb; 5(2):e9175. PubMed ID: 20161793
[TBL] [Abstract][Full Text] [Related]
4. CXCR7 stimulates MAPK signaling to regulate hepatocellular carcinoma progression.
Lin L; Han MM; Wang F; Xu LL; Yu HX; Yang PY
Cell Death Dis; 2014 Oct; 5(10):e1488. PubMed ID: 25341042
[TBL] [Abstract][Full Text] [Related]
5. Expression of CXCR7 chemokine receptor in human meningioma cells and in intratumoral microvasculature.
Würth R; Barbieri F; Bajetto A; Pattarozzi A; Gatti M; Porcile C; Zona G; Ravetti JL; Spaziante R; Florio T
J Neuroimmunol; 2011 May; 234(1-2):115-23. PubMed ID: 21316111
[TBL] [Abstract][Full Text] [Related]
6. Overexpression of CXCR7 induces angiogenic capacity of human hepatocellular carcinoma cells via the AKT signaling pathway.
Chen Y; Teng F; Wang G; Nie Z
Oncol Rep; 2016 Oct; 36(4):2275-81. PubMed ID: 27572688
[TBL] [Abstract][Full Text] [Related]
7. Common structural interactions between the receptors CXCR3, CXCR4 and CXCR7 complexed with their natural ligands, CXCL11 and CXCL12, by a modeling approach.
Costantini S; Raucci R; De Vero T; Castello G; Colonna G
Cytokine; 2013 Oct; 64(1):316-21. PubMed ID: 23773308
[TBL] [Abstract][Full Text] [Related]
8. CXCR7 impact on CXCL12 biology and disease.
Sánchez-Martín L; Sánchez-Mateos P; Cabañas C
Trends Mol Med; 2013 Jan; 19(1):12-22. PubMed ID: 23153575
[TBL] [Abstract][Full Text] [Related]
9. Chemokine receptor CXCR7 regulates the invasion, angiogenesis and tumor growth of human hepatocellular carcinoma cells.
Zheng K; Li HY; Su XL; Wang XY; Tian T; Li F; Ren GS
J Exp Clin Cancer Res; 2010 Apr; 29(1):31. PubMed ID: 20380740
[TBL] [Abstract][Full Text] [Related]
10. Androgen receptor and chemokine receptors 4 and 7 form a signaling axis to regulate CXCL12-dependent cellular motility.
Hsiao JJ; Ng BH; Smits MM; Wang J; Jasavala RJ; Martinez HD; Lee J; Alston JJ; Misonou H; Trimmer JS; Wright ME
BMC Cancer; 2015 Mar; 15():204. PubMed ID: 25884570
[TBL] [Abstract][Full Text] [Related]
11. Feedback control of the CXCR7/CXCL11 chemokine axis by estrogen receptor α in ovarian cancer.
Benhadjeba S; Edjekouane L; Sauvé K; Carmona E; Tremblay A
Mol Oncol; 2018 Oct; 12(10):1689-1705. PubMed ID: 30051594
[TBL] [Abstract][Full Text] [Related]
12. Stromal cell-derived factor-1 (SDF-1) as a target in liver diseases.
Liepelt A; Tacke F
Am J Physiol Gastrointest Liver Physiol; 2016 Aug; 311(2):G203-9. PubMed ID: 27313175
[TBL] [Abstract][Full Text] [Related]
13. The novel chemokine receptor CXCR7 regulates trans-endothelial migration of cancer cells.
Zabel BA; Lewén S; Berahovich RD; Jaén JC; Schall TJ
Mol Cancer; 2011 Jun; 10():73. PubMed ID: 21672222
[TBL] [Abstract][Full Text] [Related]
14. CXCR7 (RDC1) promotes breast and lung tumor growth in vivo and is expressed on tumor-associated vasculature.
Miao Z; Luker KE; Summers BC; Berahovich R; Bhojani MS; Rehemtulla A; Kleer CG; Essner JJ; Nasevicius A; Luker GD; Howard MC; Schall TJ
Proc Natl Acad Sci U S A; 2007 Oct; 104(40):15735-40. PubMed ID: 17898181
[TBL] [Abstract][Full Text] [Related]
15. High expression of CXCR7 combined with Alpha fetoprotein in hepatocellular carcinoma correlates with extra-hepatic metastasis to lung after hepatectomy.
Xue TC; Han D; Chen RX; Zou JH; Wang Y; Tang ZY; Ye SL
Asian Pac J Cancer Prev; 2011; 12(3):657-63. PubMed ID: 21627360
[TBL] [Abstract][Full Text] [Related]
16. CXCR7 correlates with the differentiation of hepatocellular carcinoma and suppresses HNF4α expression through the ERK pathway.
Xue TC; Jia QA; Bu Y; Chen RX; Cui JF; Tang ZY; Ye SL
Oncol Rep; 2014 Dec; 32(6):2387-96. PubMed ID: 25242412
[TBL] [Abstract][Full Text] [Related]
17. The chemokine receptor CXCR7 is highly expressed in human glioma cells and mediates antiapoptotic effects.
Hattermann K; Held-Feindt J; Lucius R; Müerköster SS; Penfold ME; Schall TJ; Mentlein R
Cancer Res; 2010 Apr; 70(8):3299-308. PubMed ID: 20388803
[TBL] [Abstract][Full Text] [Related]
18. Transmembrane receptor CXCR7 increases the risk of extrahepatic metastasis of relatively well-differentiated hepatocellular carcinoma through upregulation of osteopontin.
Xue TC; Chen RX; Ren ZG; Zou JH; Tang ZY; Ye SL
Oncol Rep; 2013 Jul; 30(1):105-10. PubMed ID: 23636305
[TBL] [Abstract][Full Text] [Related]
19. Inflammatory CXCL12-CXCR4/CXCR7 axis mediates G-protein signaling pathway to influence the invasion and migration of nasopharyngeal carcinoma cells.
Qiao N; Wang L; Wang T; Li H
Tumour Biol; 2016 Jun; 37(6):8169-79. PubMed ID: 26715277
[TBL] [Abstract][Full Text] [Related]
20. Differential effects of CXCR4-CXCL12- and CXCR7-CXCL12-mediated immune reactions on murine P0106-125 -induced experimental autoimmune neuritis.
Brunn A; Utermöhlen O; Mihelcic M; Sánchez-Ruiz M; Carstov M; Blau T; Ustinova I; Penfold M; Montesinos-Rongen M; Deckert M
Neuropathol Appl Neurobiol; 2013 Dec; 39(7):772-87. PubMed ID: 23452257
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]